Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-01-21 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司透明質酸一針及三針劑型關節腔注射劑、皮下填 補劑等系列產品取得烏克蘭國家產品銷售許可證書。
Regulatory Filings Classification · 95% confidence The document is a short announcement (762 characters) from a company disclosing the receipt of a product sales permit from Ukraine for certain medical products. It is a regulatory announcement about product certification and market expansion, not a financial report, management change, or shareholder meeting material. It does not contain financial statements, earnings data, or detailed report content. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-01-21 Chinese
公告本公司決定現金增資認股基準日等相關事宜(補充公告 代收存款機構及存儲款項機構)
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a listed company (1786 科妍) regarding decisions made by the board about a cash capital increase, including details such as the number of shares issued, issue price, subscription rights, and related dates. It includes specific information about the capital increase process, subscription ratios, and related banking arrangements. The document is short (1331 characters) and focuses on the announcement of a financing event rather than a full financial report or detailed analysis. It does not contain financial statements or comprehensive financial data. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2019-01-10 Chinese
公告本公司薪資報酬委員會委員異動
Board/Management Information Classification · 100% confidence The document is a short announcement regarding a change in the company's Compensation Committee member, specifying resignation and replacement details. It includes no financial data, no report or presentation, and is focused on management/board changes. The document length is only 646 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Board/Management Information (MANG).
2019-01-08 Chinese
公告本公司獨立董事異動
Board/Management Information Classification · 100% confidence The document is a short announcement (796 characters) about a change in the company's independent director, including details such as resignation and replacement. It does not contain financial data, audit information, or detailed reports. It is clearly an announcement of a board/management change. Therefore, it fits the category 'Board/Management Information' (MANG).
2019-01-08 Chinese
107年12月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or other corporate events. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. This type of document aligns with notifications about insider share transactions or holdings by directors and executives. Therefore, the document is best classified as a Director's Dealing report.
2019-01-07 Chinese
107年12月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and managers, with specific numbers of shares held, pledged shares, and related information. It is a disclosure of insider shareholdings and their changes, typical of a Major Shareholding Notification or insider shareholding report. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a direct disclosure of insider shareholdings. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ). The document length is under 5,000 characters but contains substantive data, so it is not a mere announcement or certification.
2019-01-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.